| 0 |
PYTHIUM INSIDIOSUM INFECTION |
2 |
0.2000 |
| 1 |
PERSISTENT GENITAL AROUSAL DISORDER |
40 |
0.1724 |
| 2 |
SLEEP DISORDER THERAPY |
34 |
0.1717 |
| 3 |
APPENDICOLITH |
58 |
0.1499 |
| 4 |
EXSEROHILUM INFECTION |
1 |
0.1250 |
| 5 |
ANALGESIC THERAPY |
34 |
0.1059 |
| 6 |
INSTILLATION SITE BRUISE |
1 |
0.1000 |
| 7 |
DRUG THERAPY |
33 |
0.0973 |
| 8 |
ANTACID THERAPY |
12 |
0.0923 |
| 9 |
OCULAR SURFACE SQUAMOUS NEOPLASIA |
2 |
0.0800 |
| 10 |
BACTEROIDES INFECTION |
19 |
0.0728 |
| 11 |
ACANTHAMOEBA KERATITIS |
2 |
0.0541 |
| 12 |
UVEAL PROLAPSE |
1 |
0.0455 |
| 13 |
MALIGNANT MELANOMA STAGE 0 |
9 |
0.0431 |
| 14 |
ANTICOAGULANT THERAPY |
12 |
0.0423 |
| 15 |
NECROTISING SCLERITIS |
6 |
0.0414 |
| 16 |
FEMALE REPRODUCTIVE TRACT DISORDER |
9 |
0.0413 |
| 17 |
SEXUAL LIFE IMPAIRMENT |
2 |
0.0408 |
| 18 |
CONGENITAL HIATUS HERNIA |
9 |
0.0395 |
| 19 |
BLOOD SMEAR TEST ABNORMAL |
3 |
0.0375 |
| 20 |
KERATITIS FUNGAL |
7 |
0.0337 |
| 21 |
INFECTIVE KERATITIS |
2 |
0.0282 |
| 22 |
INFECTIOUS CRYSTALLINE KERATOPATHY |
1 |
0.0270 |
| 23 |
CORNEAL PERFORATION |
15 |
0.0238 |
| 24 |
TEAR DISCOLOURATION |
1 |
0.0222 |
| 25 |
HYPERPHOSPHATAEMIA |
43 |
0.0200 |
| 26 |
BLOOD PHOSPHORUS INCREASED |
52 |
0.0190 |
| 27 |
NEUROTROPHIC KERATOPATHY |
1 |
0.0185 |
| 28 |
EYE INFECTION FUNGAL |
7 |
0.0181 |
| 29 |
RADICULITIS LUMBOSACRAL |
2 |
0.0180 |
| 30 |
CORNEAL INFILTRATES |
5 |
0.0159 |
| 31 |
PERINEAL PAIN |
9 |
0.0126 |
| 32 |
TOTAL LUNG CAPACITY DECREASED |
20 |
0.0125 |
| 33 |
FOREIGN BODY IN EYE |
12 |
0.0125 |
| 34 |
CORNEAL THINNING |
3 |
0.0117 |
| 35 |
BRONCHOPULMONARY ASPERGILLOSIS ALLERGIC |
10 |
0.0108 |
| 36 |
SPOROTRICHOSIS |
1 |
0.0101 |
| 37 |
DISTURBANCE IN SEXUAL AROUSAL |
9 |
0.0098 |
| 38 |
BLOOD URIC ACID INCREASED |
52 |
0.0090 |
| 39 |
IRON DEFICIENCY |
40 |
0.0089 |
| 40 |
PERSISTENT CORNEAL EPITHELIAL DEFECT |
1 |
0.0085 |
| 41 |
HYPOPYON |
7 |
0.0085 |
| 42 |
CENTRAL VENOUS PRESSURE INCREASED |
1 |
0.0082 |
| 43 |
LUNG OPACITY |
21 |
0.0080 |
| 44 |
IRIDOCELE |
1 |
0.0077 |
| 45 |
SUPERFICIAL INJURY OF EYE |
8 |
0.0073 |
| 46 |
PERICARDIAL FIBROSIS |
1 |
0.0072 |
| 47 |
LEUKAEMIC INFILTRATION |
1 |
0.0071 |
| 48 |
OCULAR SURFACE DISEASE |
2 |
0.0071 |
| 49 |
GENITAL PARAESTHESIA |
2 |
0.0069 |
| 50 |
HYPOPHOSPHATAEMIA |
51 |
0.0069 |
| 51 |
AORTIC STENOSIS |
24 |
0.0069 |
| 52 |
MYASTHENIA GRAVIS |
55 |
0.0068 |
| 53 |
APPENDICITIS |
58 |
0.0062 |
| 54 |
KERATITIS BACTERIAL |
1 |
0.0061 |
| 55 |
GENITAL PAIN |
9 |
0.0061 |
| 56 |
ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED |
27 |
0.0053 |
| 57 |
CONJUNCTIVAL DISORDER |
2 |
0.0052 |
| 58 |
VENTRICULAR FIBRILLATION |
58 |
0.0052 |
| 59 |
CORNEAL EPITHELIUM DEFECT |
3 |
0.0052 |
| 60 |
ULCERATIVE KERATITIS |
14 |
0.0051 |
| 61 |
EYE EXCISION |
1 |
0.0049 |
| 62 |
DYSBACTERIOSIS |
1 |
0.0047 |
| 63 |
OCULAR TOXICITY |
5 |
0.0045 |
| 64 |
FUSARIUM INFECTION |
3 |
0.0043 |
| 65 |
PRODUCT CONTAMINATION MICROBIAL |
5 |
0.0042 |
| 66 |
CORNEAL NEOVASCULARISATION |
1 |
0.0040 |
| 67 |
FOREIGN BODY SENSATION IN EYES |
24 |
0.0038 |
| 68 |
CARDIOGENIC SHOCK |
54 |
0.0038 |
| 69 |
SCLERAL DISORDER |
1 |
0.0037 |
| 70 |
HYPERTENSIVE URGENCY |
2 |
0.0036 |
| 71 |
CHEMICAL BURNS OF EYE |
1 |
0.0036 |
| 72 |
EYE INFECTION STAPHYLOCOCCAL |
1 |
0.0035 |
| 73 |
ANTERIOR CHAMBER INFLAMMATION |
2 |
0.0034 |
| 74 |
EYE ABSCESS |
1 |
0.0033 |
| 75 |
DYSAESTHESIA |
10 |
0.0033 |
| 76 |
TROPONIN INCREASED |
24 |
0.0032 |
| 77 |
RIGHT VENTRICULAR ENLARGEMENT |
1 |
0.0031 |
| 78 |
SOFT TISSUE INFLAMMATION |
1 |
0.0030 |
| 79 |
GRAFT INFECTION |
1 |
0.0029 |
| 80 |
CORNEAL OPACITY |
4 |
0.0029 |
| 81 |
POSTERIOR CAPSULE OPACIFICATION |
1 |
0.0029 |
| 82 |
MYCOBACTERIUM CHELONAE INFECTION |
2 |
0.0027 |
| 83 |
BACTERIAL INFECTION |
50 |
0.0027 |
| 84 |
CORNEAL TRANSPLANT |
2 |
0.0026 |
| 85 |
BLOOD CALCIUM INCREASED |
22 |
0.0025 |
| 86 |
INCORRECT ROUTE OF PRODUCT ADMINISTRATION |
42 |
0.0024 |
| 87 |
STAPHYLOCOCCAL SKIN INFECTION |
3 |
0.0024 |
| 88 |
NEURALGIA |
55 |
0.0023 |
| 89 |
PRODUCT RESIDUE PRESENT |
12 |
0.0022 |
| 90 |
PLEURITIC PAIN |
6 |
0.0022 |
| 91 |
KERATIC PRECIPITATES |
1 |
0.0021 |
| 92 |
THERAPY RESPONDER |
1 |
0.0020 |
| 93 |
COMPLICATIONS OF TRANSPLANT SURGERY |
1 |
0.0020 |
| 94 |
KERATITIS |
6 |
0.0020 |
| 95 |
ASCITES |
58 |
0.0020 |
| 96 |
MULTIPLE ORGAN DYSFUNCTION SYNDROME |
55 |
0.0019 |
| 97 |
PRODUCT DEPOSIT |
3 |
0.0019 |
| 98 |
CHOROIDAL DETACHMENT |
1 |
0.0018 |
| 99 |
SUSPECTED PRODUCT TAMPERING |
1 |
0.0018 |
| 100 |
RESPIRATORY SYMPTOM |
5 |
0.0018 |
| 101 |
HYPERLIPIDAEMIA |
21 |
0.0018 |
| 102 |
BENIGN PROSTATIC HYPERPLASIA |
9 |
0.0017 |
| 103 |
ULCER |
27 |
0.0017 |
| 104 |
BLOOD TEST ABNORMAL |
23 |
0.0016 |
| 105 |
PRODUCT PHYSICAL CONSISTENCY ISSUE |
9 |
0.0016 |
| 106 |
ENDOPHTHALMITIS |
9 |
0.0015 |
| 107 |
MEDICATION RESIDUE PRESENT |
7 |
0.0015 |
| 108 |
ANTERIOR CHAMBER CELL |
1 |
0.0014 |
| 109 |
GOUT |
25 |
0.0014 |
| 110 |
LABELLED DRUG-DRUG INTERACTION ISSUE |
2 |
0.0014 |
| 111 |
END STAGE RENAL DISEASE |
25 |
0.0014 |
| 112 |
CORNEAL DISORDER |
3 |
0.0014 |
| 113 |
EYE INJURY |
4 |
0.0013 |
| 114 |
IRON DEFICIENCY ANAEMIA |
12 |
0.0013 |
| 115 |
NEURITIS |
2 |
0.0013 |
| 116 |
SUPERIOR SAGITTAL SINUS THROMBOSIS |
1 |
0.0013 |
| 117 |
LIQUID PRODUCT PHYSICAL ISSUE |
9 |
0.0012 |
| 118 |
FEAR OF FALLING |
1 |
0.0012 |
| 119 |
SEPTIC EMBOLUS |
1 |
0.0012 |
| 120 |
VITREOUS OPACITIES |
1 |
0.0012 |
| 121 |
FOOD INTERACTION |
2 |
0.0011 |
| 122 |
BLOOD CHOLESTEROL INCREASED |
51 |
0.0011 |
| 123 |
OCULAR DISCOMFORT |
12 |
0.0011 |
| 124 |
HYPONATRAEMIA |
58 |
0.0010 |
| 125 |
BREATH SOUNDS ABNORMAL |
5 |
0.0010 |
| 126 |
CHRONIC OBSTRUCTIVE PULMONARY DISEASE |
52 |
0.0010 |
| 127 |
ASPIRATION |
10 |
0.0009 |
| 128 |
CARDIAC HYPERTROPHY |
1 |
0.0009 |
| 129 |
RALES |
5 |
0.0009 |
| 130 |
PHYSICAL PRODUCT LABEL ISSUE |
1 |
0.0008 |
| 131 |
DYSPLASIA |
1 |
0.0008 |
| 132 |
EYE DISCHARGE |
8 |
0.0008 |
| 133 |
SEXUAL DYSFUNCTION |
9 |
0.0008 |
| 134 |
ASPERGILLOSIS |
1 |
0.0008 |
| 135 |
SLEEP DISORDER |
53 |
0.0008 |
| 136 |
BRONCHIECTASIS |
5 |
0.0007 |
| 137 |
DIABETES MELLITUS |
56 |
0.0007 |
| 138 |
CORNEAL ABRASION |
1 |
0.0007 |
| 139 |
EYE PAIN |
41 |
0.0007 |
| 140 |
DRY MOUTH |
57 |
0.0007 |
| 141 |
MICTURITION URGENCY |
8 |
0.0007 |
| 142 |
CEREBELLAR HAEMORRHAGE |
1 |
0.0007 |
| 143 |
THROMBOSIS |
55 |
0.0007 |
| 144 |
IMPETIGO |
1 |
0.0007 |
| 145 |
PATHOGEN RESISTANCE |
6 |
0.0007 |
| 146 |
INCORRECT DOSE ADMINISTERED BY PRODUCT |
1 |
0.0006 |
| 147 |
SCLERITIS |
1 |
0.0006 |
| 148 |
LIVER FUNCTION TEST INCREASED |
13 |
0.0006 |
| 149 |
INTENTIONAL PRODUCT MISUSE |
53 |
0.0006 |
| 150 |
RETINAL THICKENING |
1 |
0.0006 |
| 151 |
SWELLING |
56 |
0.0006 |
| 152 |
POTENTIATING DRUG INTERACTION |
2 |
0.0006 |
| 153 |
ABDOMINAL DISTENSION |
62 |
0.0006 |
| 154 |
PSEUDOMONAS INFECTION |
5 |
0.0006 |
| 155 |
PULMONARY EMBOLISM |
51 |
0.0005 |
| 156 |
DRUG INTOLERANCE |
51 |
0.0005 |
| 157 |
LOWER RESPIRATORY TRACT INFECTION |
24 |
0.0005 |
| 158 |
SPUTUM DISCOLOURED |
5 |
0.0005 |
| 159 |
EYE INFLAMMATION |
5 |
0.0005 |
| 160 |
HYPERCHOLESTEROLAEMIA |
5 |
0.0005 |
| 161 |
SEPSIS |
55 |
0.0005 |
| 162 |
GENERAL PHYSICAL HEALTH DETERIORATION |
57 |
0.0005 |
| 163 |
EYELID PAIN |
1 |
0.0005 |
| 164 |
FULL BLOOD COUNT ABNORMAL |
5 |
0.0005 |
| 165 |
ABNORMAL SENSATION IN EYE |
2 |
0.0005 |
| 166 |
OBSTRUCTIVE AIRWAYS DISORDER |
5 |
0.0004 |
| 167 |
CORNEAL OEDEMA |
1 |
0.0004 |
| 168 |
SUSPECTED OFF LABEL USE |
2 |
0.0004 |
| 169 |
OCULAR HYPERAEMIA |
21 |
0.0004 |
| 170 |
EYE IRRITATION |
25 |
0.0004 |
| 171 |
VENOOCCLUSIVE DISEASE |
1 |
0.0004 |
| 172 |
BLOOD CREATININE INCREASED |
26 |
0.0004 |
| 173 |
PRODUCT SOLUBILITY ABNORMAL |
2 |
0.0004 |
| 174 |
PRODUCT CONTAMINATION PHYSICAL |
1 |
0.0004 |
| 175 |
PRODUCT COLOUR ISSUE |
2 |
0.0004 |
| 176 |
RETINAL DISORDER |
1 |
0.0004 |
| 177 |
PLEURAL EFFUSION |
23 |
0.0004 |
| 178 |
JOINT INJURY |
8 |
0.0004 |
| 179 |
PRODUCT DELIVERY MECHANISM ISSUE |
2 |
0.0004 |
| 180 |
ASTHENOPIA |
2 |
0.0004 |
| 181 |
TRANSAMINASES INCREASED |
8 |
0.0004 |
| 182 |
EYE INFECTION |
4 |
0.0004 |
| 183 |
EYELID MARGIN CRUSTING |
1 |
0.0003 |
| 184 |
PULMONARY MASS |
5 |
0.0003 |
| 185 |
CONDITION AGGRAVATED |
100 |
0.0003 |
| 186 |
SQUAMOUS CELL CARCINOMA |
3 |
0.0003 |
| 187 |
SOMNOLENCE |
64 |
0.0003 |
| 188 |
VAGINAL DISCHARGE |
3 |
0.0003 |
| 189 |
HAEMOPTYSIS |
8 |
0.0003 |
| 190 |
MUSCULOSKELETAL STIFFNESS |
25 |
0.0003 |
| 191 |
THROMBOPHLEBITIS |
1 |
0.0003 |
| 192 |
POOR QUALITY PRODUCT ADMINISTERED |
3 |
0.0003 |
| 193 |
CONJUNCTIVAL HYPERAEMIA |
1 |
0.0003 |
| 194 |
RENAL TRANSPLANT |
1 |
0.0003 |
| 195 |
ANAEMIA |
52 |
0.0003 |
| 196 |
LACRIMATION INCREASED |
8 |
0.0003 |
| 197 |
CORONARY ARTERY DISEASE |
8 |
0.0003 |
| 198 |
PROCEDURAL COMPLICATION |
2 |
0.0003 |
| 199 |
PULMONARY FIBROSIS |
5 |
0.0003 |
| 200 |
CONSTIPATION |
56 |
0.0003 |
| 201 |
ABDOMINAL PAIN |
59 |
0.0003 |
| 202 |
PNEUMONIA FUNGAL |
1 |
0.0003 |
| 203 |
BLOOD DISORDER |
2 |
0.0002 |
| 204 |
TRIGEMINAL NEURALGIA |
1 |
0.0002 |
| 205 |
GENERALISED OEDEMA |
3 |
0.0002 |
| 206 |
PRODUCT DISPENSING ISSUE |
1 |
0.0002 |
| 207 |
TONGUE DISCOLOURATION |
1 |
0.0002 |
| 208 |
FACIAL PAIN |
2 |
0.0002 |
| 209 |
CONJUNCTIVITIS |
4 |
0.0002 |
| 210 |
OEDEMA PERIPHERAL |
26 |
0.0002 |
| 211 |
PHOTOPHOBIA |
4 |
0.0002 |
| 212 |
TRANSIENT ISCHAEMIC ATTACK |
7 |
0.0002 |
| 213 |
ASPARTATE AMINOTRANSFERASE INCREASED |
11 |
0.0002 |
| 214 |
TREATMENT FAILURE |
17 |
0.0002 |
| 215 |
IMMUNE RECONSTITUTION INFLAMMATORY SYNDROME |
1 |
0.0002 |
| 216 |
CARDIOVASCULAR DISORDER |
5 |
0.0002 |
| 217 |
EYELID PTOSIS |
2 |
0.0002 |
| 218 |
UPPER RESPIRATORY TRACT INFECTION |
9 |
0.0002 |
| 219 |
PRODUCT TEMPERATURE EXCURSION ISSUE |
1 |
0.0002 |
| 220 |
NONSPECIFIC REACTION |
1 |
0.0002 |
| 221 |
SKIN TOXICITY |
1 |
0.0002 |
| 222 |
DERMATITIS CONTACT |
2 |
0.0002 |
| 223 |
CATARACT OPERATION |
1 |
0.0002 |
| 224 |
FOETAL GROWTH RESTRICTION |
1 |
0.0002 |
| 225 |
SWELLING OF EYELID |
1 |
0.0002 |
| 226 |
POOR QUALITY DRUG ADMINISTERED |
1 |
0.0002 |
| 227 |
ASPERGILLUS INFECTION |
1 |
0.0002 |
| 228 |
ADVERSE REACTION |
2 |
0.0002 |
| 229 |
PRODUCT PHYSICAL ISSUE |
3 |
0.0001 |
| 230 |
HYPERTENSION |
31 |
0.0001 |
| 231 |
RIGHT VENTRICULAR FAILURE |
1 |
0.0001 |
| 232 |
BURNING SENSATION |
10 |
0.0001 |
| 233 |
PULMONARY TOXICITY |
1 |
0.0001 |
| 234 |
RETINAL HAEMORRHAGE |
1 |
0.0001 |
| 235 |
GRAFT VERSUS HOST DISEASE |
1 |
0.0001 |
| 236 |
LIVER DISORDER |
6 |
0.0001 |
| 237 |
HEPATOTOXICITY |
3 |
0.0001 |
| 238 |
PRODUCT USE IN UNAPPROVED INDICATION |
33 |
0.0001 |
| 239 |
THYROID DISORDER |
2 |
0.0001 |
| 240 |
LOW BIRTH WEIGHT BABY |
1 |
0.0001 |
| 241 |
GINGIVAL PAIN |
1 |
0.0001 |
| 242 |
VOMITING |
59 |
0.0001 |
| 243 |
SENSORY DISTURBANCE |
2 |
0.0001 |
| 244 |
FRUSTRATION TOLERANCE DECREASED |
1 |
0.0001 |
| 245 |
DRUG LEVEL INCREASED |
2 |
0.0001 |
| 246 |
VISUAL ACUITY REDUCED |
4 |
0.0001 |
| 247 |
LEUKOPENIA |
6 |
0.0001 |
| 248 |
EYE PRURITUS |
4 |
0.0001 |
| 249 |
INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION |
21 |
0.0001 |
| 250 |
HYPOXIA |
4 |
0.0001 |
| 251 |
PURPURA |
1 |
0.0001 |
| 252 |
FEAR |
3 |
0.0001 |
| 253 |
RETINAL DETACHMENT |
1 |
0.0001 |
| 254 |
DRUG-INDUCED LIVER INJURY |
3 |
0.0001 |
| 255 |
INCONTINENCE |
1 |
0.0001 |
| 256 |
SUDDEN DEATH |
1 |
0.0001 |
| 257 |
HYPOTHYROIDISM |
3 |
0.0001 |
| 258 |
DYSPNOEA |
53 |
0.0001 |
| 259 |
OFF LABEL USE |
81 |
0.0001 |
| 260 |
BLOOD CALCIUM DECREASED |
1 |
0.0001 |
| 261 |
DRUG INEFFECTIVE |
117 |
0.0001 |
| 262 |
ASTHMA |
10 |
0.0001 |
| 263 |
PRODUCT QUALITY ISSUE |
12 |
0.0001 |
| 264 |
GASTROOESOPHAGEAL REFLUX DISEASE |
7 |
0.0001 |
| 265 |
GASTRIC HAEMORRHAGE |
1 |
0.0001 |
| 266 |
DRUG INTERACTION |
13 |
0.0001 |
| 267 |
LUNG DISORDER |
4 |
0.0001 |
| 268 |
DYSURIA |
3 |
0.0001 |
| 269 |
EYE SWELLING |
3 |
0.0001 |
| 270 |
BRAIN OEDEMA |
1 |
0.0001 |
| 271 |
INTRAOCULAR PRESSURE INCREASED |
1 |
0.0001 |
| 272 |
GASTROINTESTINAL DISORDER |
7 |
0.0001 |
| 273 |
IMMUNE SYSTEM DISORDER |
1 |
0.0001 |
| 274 |
PRODUCT DOSE OMISSION ISSUE |
22 |
0.0001 |
| 275 |
QUALITY OF LIFE DECREASED |
1 |
0.0001 |
| 276 |
DISTURBANCE IN ATTENTION |
4 |
0.0001 |
| 277 |
PNEUMONIA |
24 |
0.0001 |
| 278 |
NAUSEA |
58 |
0.0001 |
| 279 |
BLINDNESS UNILATERAL |
1 |
0.0001 |
| 280 |
ANOSMIA |
1 |
0.0001 |
| 281 |
HYPERTHYROIDISM |
1 |
0.0001 |
| 282 |
PRODUCT STORAGE ERROR |
6 |
0.0001 |
| 283 |
HAEMORRHAGE INTRACRANIAL |
1 |
0.0001 |
| 284 |
THERAPY NON-RESPONDER |
3 |
0.0001 |
| 285 |
PREMATURE BABY |
2 |
0.0001 |
| 286 |
ECONOMIC PROBLEM |
1 |
0.0001 |
| 287 |
DRUG DISPENSING ERROR |
1 |
0.0001 |
| 288 |
VISUAL IMPAIRMENT |
8 |
0.0001 |
| 289 |
THERAPY PARTIAL RESPONDER |
1 |
0.0001 |
| 290 |
PRODUCT USE ISSUE |
12 |
0.0001 |
| 291 |
ANXIETY |
18 |
0.0001 |
| 292 |
PREMATURE DELIVERY |
1 |
0.0001 |
| 293 |
EYE DISORDER |
2 |
0.0001 |
| 294 |
FUNGAL INFECTION |
2 |
0.0001 |
| 295 |
PERICARDITIS |
1 |
0.0001 |
| 296 |
UPPER GASTROINTESTINAL HAEMORRHAGE |
1 |
0.0001 |
| 297 |
DISEASE PROGRESSION |
7 |
0.0001 |
| 298 |
VISION BLURRED |
8 |
0.0001 |
| 299 |
DEVICE USE ISSUE |
1 |
0.0001 |
| 300 |
NEUROTOXICITY |
1 |
0.0001 |
| 301 |
DERMATITIS ATOPIC |
3 |
0.0001 |
| 302 |
THIRST |
1 |
0.0001 |
| 303 |
MEDICATION ERROR |
3 |
0.0001 |
| 304 |
GLAUCOMA |
1 |
0.0001 |
| 305 |
WHEEZING |
3 |
0.0001 |
| 306 |
PRODUCT ADMINISTRATION ERROR |
1 |
0.0000 |
| 307 |
BONE MARROW FAILURE |
1 |
0.0000 |
| 308 |
MELAENA |
1 |
0.0000 |
| 309 |
HEPATIC ENZYME INCREASED |
3 |
0.0000 |
| 310 |
PRODUCT AVAILABILITY ISSUE |
1 |
0.0000 |
| 311 |
PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME |
1 |
0.0000 |
| 312 |
COGNITIVE DISORDER |
2 |
0.0000 |
| 313 |
TREMOR |
7 |
0.0000 |
| 314 |
BLOOD ALKALINE PHOSPHATASE INCREASED |
1 |
0.0000 |
| 315 |
HAEMATEMESIS |
1 |
0.0000 |
| 316 |
DRUG RESISTANCE |
1 |
0.0000 |
| 317 |
INFLAMMATION |
2 |
0.0000 |
| 318 |
MUCOSAL INFLAMMATION |
1 |
0.0000 |
| 319 |
ANHEDONIA |
1 |
0.0000 |
| 320 |
FREQUENT BOWEL MOVEMENTS |
1 |
0.0000 |
| 321 |
MOOD ALTERED |
1 |
0.0000 |
| 322 |
SKIN LESION |
1 |
0.0000 |
| 323 |
DRUG INEFFECTIVE FOR UNAPPROVED INDICATION |
2 |
0.0000 |
| 324 |
WOUND |
1 |
0.0000 |
| 325 |
PAIN IN JAW |
1 |
0.0000 |
| 326 |
FLATULENCE |
2 |
0.0000 |
| 327 |
DRUG EFFECTIVE FOR UNAPPROVED INDICATION |
1 |
0.0000 |
| 328 |
HEPATIC FAILURE |
1 |
0.0000 |
| 329 |
FEELING HOT |
2 |
0.0000 |
| 330 |
FEMUR FRACTURE |
1 |
0.0000 |
| 331 |
ASTHENIA |
12 |
0.0000 |
| 332 |
MOOD SWINGS |
1 |
0.0000 |
| 333 |
CONTUSION |
3 |
0.0000 |
| 334 |
PAIN |
19 |
0.0000 |
| 335 |
IMPAIRED HEALING |
1 |
0.0000 |
| 336 |
DEATH |
26 |
0.0000 |
| 337 |
EXPIRED PRODUCT ADMINISTERED |
1 |
0.0000 |
| 338 |
ABDOMINAL PAIN UPPER |
6 |
0.0000 |
| 339 |
GASTRIC DISORDER |
1 |
0.0000 |
| 340 |
RASH MACULAR |
1 |
0.0000 |
| 341 |
CEREBRAL HAEMORRHAGE |
1 |
0.0000 |
| 342 |
THROMBOCYTOPENIA |
3 |
0.0000 |
| 343 |
EPISTAXIS |
2 |
0.0000 |
| 344 |
PYREXIA |
9 |
0.0000 |
| 345 |
ABNORMAL BEHAVIOUR |
1 |
0.0000 |
| 346 |
DISORIENTATION |
1 |
0.0000 |
| 347 |
FOETAL EXPOSURE DURING PREGNANCY |
2 |
0.0000 |
| 348 |
BLINDNESS |
1 |
0.0000 |
| 349 |
POLLAKIURIA |
1 |
0.0000 |
| 350 |
RENAL FAILURE ACUTE |
1 |
0.0000 |
| 351 |
HYPOACUSIS |
1 |
0.0000 |
| 352 |
PULMONARY OEDEMA |
1 |
0.0000 |
| 353 |
MEMORY IMPAIRMENT |
3 |
0.0000 |
| 354 |
SKIN IRRITATION |
1 |
0.0000 |
| 355 |
ARRHYTHMIA |
1 |
0.0000 |
| 356 |
COMA |
1 |
0.0000 |
| 357 |
ATRIAL FIBRILLATION |
2 |
0.0000 |
| 358 |
DRY EYE |
1 |
0.0000 |
| 359 |
HEADACHE |
12 |
0.0000 |
| 360 |
HAEMATOCHEZIA |
1 |
0.0000 |
| 361 |
FATIGUE |
14 |
0.0000 |
| 362 |
OXYGEN SATURATION DECREASED |
1 |
0.0000 |
| 363 |
DEPRESSION |
4 |
0.0000 |
| 364 |
SURGERY |
1 |
0.0000 |
| 365 |
CATARACT |
1 |
0.0000 |
| 366 |
ILL-DEFINED DISORDER |
1 |
0.0000 |
| 367 |
VERTIGO |
1 |
0.0000 |
| 368 |
EXPOSURE DURING PREGNANCY |
1 |
0.0000 |
| 369 |
BLOOD GLUCOSE INCREASED |
3 |
0.0000 |
| 370 |
INJECTION SITE REACTION |
1 |
0.0000 |
| 371 |
COUGH |
4 |
0.0000 |
| 372 |
THERAPY INTERRUPTED |
1 |
0.0000 |
| 373 |
RESPIRATORY FAILURE |
1 |
0.0000 |
| 374 |
AGITATION |
1 |
0.0000 |
| 375 |
DYSGEUSIA |
1 |
0.0000 |
| 376 |
CHRONIC KIDNEY DISEASE |
1 |
0.0000 |
| 377 |
ACUTE KIDNEY INJURY |
2 |
0.0000 |
| 378 |
PARAESTHESIA |
2 |
0.0000 |
| 379 |
DRUG ABUSE |
1 |
0.0000 |
| 380 |
RENAL IMPAIRMENT |
1 |
0.0000 |
| 381 |
INTENTIONAL PRODUCT USE ISSUE |
1 |
0.0000 |
| 382 |
ADVERSE EVENT |
1 |
0.0000 |
| 383 |
HEART RATE INCREASED |
1 |
0.0000 |
| 384 |
ERYTHEMA |
2 |
0.0000 |
| 385 |
PLATELET COUNT DECREASED |
1 |
0.0000 |
| 386 |
INFLUENZA |
1 |
0.0000 |
| 387 |
INCORRECT DOSE ADMINISTERED |
2 |
0.0000 |
| 388 |
EMOTIONAL DISTRESS |
1 |
0.0000 |
| 389 |
DIARRHOEA |
5 |
0.0000 |
| 390 |
RENAL FAILURE |
1 |
0.0000 |
| 391 |
INSOMNIA |
2 |
0.0000 |
| 392 |
INFECTION |
1 |
0.0000 |
| 393 |
PERIPHERAL SWELLING |
1 |
0.0000 |
| 394 |
CONFUSIONAL STATE |
1 |
0.0000 |
| 395 |
ABDOMINAL DISCOMFORT |
1 |
0.0000 |
| 396 |
TOXICITY TO VARIOUS AGENTS |
1 |
0.0000 |
| 397 |
MUSCLE SPASMS |
1 |
0.0000 |
| 398 |
HYPERSENSITIVITY |
1 |
0.0000 |
| 399 |
GAIT DISTURBANCE |
1 |
0.0000 |
| 400 |
PRURITUS |
2 |
0.0000 |
| 401 |
WRONG TECHNIQUE IN PRODUCT USAGE PROCESS |
1 |
0.0000 |
| 402 |
RASH |
2 |
0.0000 |
| 403 |
WEIGHT INCREASED |
1 |
0.0000 |
| 404 |
DECREASED APPETITE |
1 |
0.0000 |
| 405 |
FEELING ABNORMAL |
1 |
0.0000 |
| 406 |
DIZZINESS |
2 |
0.0000 |
| 407 |
WEIGHT DECREASED |
1 |
0.0000 |
| 408 |
PAIN IN EXTREMITY |
1 |
0.0000 |